US Patent Issued to Holobiome on Aug. 26 for "Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,022, issued on Aug. 26, was assigned to Holobiome Inc. (Boston).

"Modulation of the gut microbiome to treat mental disorders or diseases of the central nervous system" was invented by Philip Strandwitz (Medford, Mass.) and Kim Lewis (Newton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of treating at least one symptom of a mental disorder or disease of the central nervous system in a subject by modulating the amount of GABA produced in the subject's gut. The present disclosure also relates to methods of culturing the bacterial strain new bacterial strains. Also disclosed are methods of identifying ba...